In contrast, the risk of developing an ER-/PR- CBC was fivefold greater among women with ER-/PR- first breast cancer than among those with ER+/PR+ first cancer (RR = 5.4, 95% CI 3.0–9.5). Here, ESR1 is linked to breast carcinoma.